Literature DB >> 2123878

Purification, characterization, and western blot analysis of human GTPase-activating protein from native and recombinant sources.

R Halenbeck1, W J Crosier, R Clark, F McCormick, K Koths.   

Abstract

Human ras GTPase-activating protein (GAP) is a cytoplasmic factor that stimulates the GTPase activity of normal N-ras p21 while having no stimulatory effect on the GTPase activity of oncogenic variants of N-ras p21. We have purified two forms of native ras GAP from human placental tissue. In addition to the Mr = 120,000 type I GAP reported previously (1), an equivalent amount of an Mr = 95,000 molecule with GAP activity was recovered and shown to have the N-terminal sequence expected for type II GAP. The two GAP forms in placental extracts were resolved by molecular sieve chromatography and appeared to have a monomeric native structure. Human recombinant type I GAP was produced intracellularly in Sf9 insect cells using a baculovirus expression vector, and 10-mg quantities were purified to homogeneity in three steps. Comparison of the purified native and recombinant GAP molecules revealed that all three displayed similar biological specific activities in an in vitro GAP assay. A polyclonal antibody to purified recombinant GAP was prepared and shown to neutralize the activity of both native and recombinant GAPs. The antibody was also highly specific for the detection of native GAP by Western blot. Type I and II GAP species were detected in approximately equal amounts in cytoplasmic extracts of human placenta, but only type I GAP was observed when other human tissues were examined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation.

Authors:  E Filvaroff; E Calautti; F McCormick; G P Dotto
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Mutational and kinetic analyses of the GTPase-activating protein (GAP)-p21 interaction: the C-terminal domain of GAP is not sufficient for full activity.

Authors:  P Gideon; J John; M Frech; A Lautwein; R Clark; J E Scheffler; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Ras GTPase-activating protein: a substrate and a potential binding protein of the protein-tyrosine kinase p56lck.

Authors:  K E Amrein; N Flint; B Panholzer; P Burn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Functional role of GTPase-activating protein in cell transformation by pp60v-src.

Authors:  J E DeClue; W C Vass; M R Johnson; D W Stacey; D R Lowy
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

5.  Differential regulation of cellular activities by GTPase-activating protein and NF1.

Authors:  N al-Alawi; G Xu; R White; R Clark; F McCormick; J R Feramisco
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

6.  Expression of the placenta-specific, 100 kDa ras GTPase activating protein in several human cancer cell lines and normal human tissues.

Authors:  Y Araki; K Nakamura; Y Chijiiwa; H Nawata
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

7.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

Authors:  S Munemitsu; I Albert; B Souza; B Rubinfeld; P Polakis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation.

Authors:  M Pomerance; M N Thang; B Tocque; M Pierre
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.

Authors:  M R Johnson; J E DeClue; S Felzmann; W C Vass; G Xu; R White; D R Lowy
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Epinephrine suppresses rap1B.GAP-activated GTPase activity in human platelets.

Authors:  K B Marti; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.